바이오인프라생명과학 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 블랑두부, was filed 16 Dec 2024.
바이오인프라생명과학: what insiders have been doing
This page follows insider dealings at 바이오인프라생명과학 as filed with DART (FSS), a company from the Health Care sector. No insider at 바이오인프라생명과학 has published a filing in the past twelve months. The most recent one dates from 16 December 2024.
Elsewhere in the same sector, our signals recently picked up insider purchases at Relmada Therapeutics, Inc. and MAIA Biotechnology, Inc. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Who traded when
BuySaleFinancial data
· cache
- 3,000,000 sharesKRXDART:20241216000030Canonical exit: 7 Mar 2025 (T+90)
- ShareKRXDART:20241216000031Canonical exit: 7 Mar 2025 (T+90)
- ShareKRXDART:20241212000384Canonical exit: 7 Mar 2025 (T+90)
- 3,200,000 sharesKRXDART:20241212000376Canonical exit: 7 Mar 2025 (T+90)
- 3,000,000 sharesKRXDART:20241022000179Canonical exit: 20 Jan 2025 (T+90)
- ShareKRXDART:20241022000125Canonical exit: 29 Nov 2024 (T+90)
- ShareKRXDART:20240906000663
- 345,920 sharesKRXDART:20240906000668
- 3,263,000 sharesKRXDART:20240904000458Canonical exit: 29 Nov 2024 (T+90)
- 3,263,000 sharesKRXDART:20210621000256Canonical exit: 19 Sept 2021 (T+90)
- 3,263,000 sharesKRXDART:20210527000096Canonical exit: 25 Aug 2021 (T+90)
- 3,263,000 sharesKRXDART:20210426000238Canonical exit: 25 Jul 2021 (T+90)
12 of 12 declarations
About 바이오인프라생명과학
BioInfra Life Science is a company specializing in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions for medical needs.
